Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 682 of 6351
-
Fish oil for faster, smarter athletes? a trial puts Omega-3s to the test
Disease control Recruiting nowThe aim of this study is to evaluate the effects of omega-3 fatty acid supplementation on the Omega-3 Index, erythrocyte membrane composition, cognitive function, hormonal profile, speed, endurance performance, and hematological parameters in competitive athletes aged 16-35 years…
Sponsor: The Jerzy Kukuczka Academy of Physical Education in Katowice • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Light-Activated gel shows promise for rare skin cancer
Disease control Stopped earlyTo evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
Phase 3 • Sponsor: Soligenix • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Higher buprenorphine dose may keep more people in opioid treatment
Disease control Recruiting nowThe investigators aim to test the effectiveness of a high maintenance daily dose of buprenorphine (24 mg) for improving outcomes among patients who used fentanyl compared to the standard daily dose (16 mg). The main question it aims to answer is: will patients who are randomly a…
Phase 2/3 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for advanced breast cancer: phase 3 trial launches
Disease control OngoingThe purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people with breast cancer: * HR-positive (breast cancer cells that need estrogen or prog…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug targets Hard-to-Treat cancers in major trial
Disease control OngoingThis pan-tumor trial is designed as a signal-seeking trial to assess efficacy and safety of raludotatug deruxtecan (R-DXd) monotherapy in locally advanced or metastatic solid tumors with various cadherin-6 (CDH6) expression levels, including gynecological cancers (endometrial can…
Phase 2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immune cell therapy shows promise for tough autoimmune cases
Disease control Recruiting nowThis study is a single-center, open-label, single-arm, dose-escalation trial. The aim of this study is to investigate the safety and efficacy of Anti-CD19 IL-10/IL15 CAR-NK cells in patients with refractory/relapsed autoimmune diseases, including systemic lupus erythematosus, sys…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Sleep drug may shield Seniors' brains after heart surgery
Disease control Recruiting nowThis is a pragmatic phase III, randomized, blinded, double placebo-controlled, three-arm trial of elderly patients following cardiac surgery to assess the relationship between nighttime intravenous (IV) and sublingual dexmedetomidine on postoperative delirium and functional outco…
Phase 3 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Laser and Light-Sensitive drug aim to zap prostate cancer without surgery
Disease control Recruiting nowThe goal of this study is to obtain safety data, establish dose parameters, and effectiveness of treatment for the SpectraCure P18 System with IDOSE®, together with verteporfin for injection (VFI) as photosensitizer, for the treatment of primary localized prostate cancer. The st…
Phase 1/2 • Sponsor: SpectraCure AB • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New combo therapy aims to save rectums in advanced cancer patients
Disease control Recruiting nowColorectal cancer ranks as the third most prevalent malignancy worldwide and the second leading cause of cancer-related mortality. For patients with locally advanced rectal cancer (LARC) classified as T3-4/N+ without distant metastasis, achieving organ preservation and functional…
Phase 2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug cocktail aims to shrink tough prostate tumors before surgery
Disease control Recruiting nowResearchers conducting this study hope to learn about the safety and effectiveness of combining two study drugs, relacorilant and enzalutamide, plus androgen deprivation therapy (ADT), also known as hormone therapy. This study is for individuals who have been diagnosed with advan…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New combo therapy offers hope for hard-to-treat rectal cancer
Disease control Recruiting nowThis is a prospective study to delve into the therapeutic benefits of combining stereotactic body radiation therapy (SBRT) with PD-1 monoclonal antibody treatment for patients with unresectable locally recurrent rectal cancer (ULRRC). Our aim is to ascertain the safety of this ap…
Phase 2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
AI-Powered heart scans aim to predict deadly complications in muscular dystrophy
Knowledge-focused Recruiting nowDystrophin associated heart dysfunction is a leading cause of death in patients with Duchenne and Becker Muscular dystrophy (DMD/BMD) and Duchenne and Becker muscular dystrophy carriers (MDC); however, the evolution of heart dysfunction is not well-understood. The central objecti…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Intensive therapy during a hospital stay may boost recovery for young trauma survivors
Symptom relief CompletedThis study looks at a treatment program for children and teens who have post-traumatic stress disorder (PTSD) after sexual abuse. The program is called II-TF-CBT. It is a special version of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), a type of cognitive behavioral thera…
Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Could online therapy ease the stress of raising a child with autism?
Symptom relief CompletedThe aim of this study to evaluate the effectiveness of an online psychological support program for mothers of children diagnosed with Autism Spectrum Disorder (ASD). In this study, investigators aim to assess the impact of the psychological support program on mothers' mental heal…
Sponsor: Sabri Hergüner • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Immunotherapy plus chemo shows promise against tough stomach cancer
Disease control OngoingThe goal of this clinical trial is to learn if FLOT chemotherapy combined with serplulimab can improve the pathological complete response (pCR) rate in patients with stage III gastric cancer. The main question it aims to answer is: Can FLOT chemotherapy combined with serplulimab…
Phase 2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for hard-to-treat ovarian cancer: targeted drug combo enters trial
Disease control Recruiting nowOvarian cancer exhibits the highest mortality rate among gynecological malignancies. Currently, the combination of paclitaxel and carboplatin remains the standard first-line chemotherapy regimen for neoadjuvant or postoperative treatment of ovarian cancer. However, conventional p…
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for Tough-to-Treat blood cancers: pirtobrutinib trial launches
Disease control Recruiting nowThe main purpose of Part 1 of this study is to assess the efficacy and safety of 3 dose levels of Pirtobrutinib in participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), who have received 1-3 lines of treatment including a covalent Bruton tyrosi…
Phase 2 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New immunotherapy combo takes on advanced liver cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Adabrelimab (arterial or intravenous administration) combined with hepatic artery FOLFOX infusion chemotherapy and Bevacizumab as the first-line treatment of advanced stage hepatocellular carcinoma. Patients will…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Promising new combo tackles tough leukemia
Disease control Recruiting nowThis phase II trial tests how well venetoclax with cladribine and cytarabine alternating with azacitidine and venetoclax works in treating patients with newly diagnosed monocytic acute myeloid leukemia (AML) and active signaling mutated AML. Venetoclax is in a class of medication…
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Brain zaps for war trauma? new TMS study hints at faster PTSD relief
Symptom relief CompletedPosttraumatic stress disorder (PTSD) among military service members and veterans is as high as 32% and is the third most service-connected disability, resulting in over $1.5 billion in direct costs over a five-year period. According to Clinical Practice Guidelines, strong evidenc…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC